Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

91,531 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Choosing Between Older Matched Sibling Donor and Younger Matched Unrelated Donor in Allogeneic Hematopoietic Cell Transplantation: Comparison of Clinical Outcomes in Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Pereira MP, Remberger M, Chen C, Gerbitz A, Kim DDH, Kumar R, Lam W, Law AD, Lipton JH, Michelis FV, Novitzky-Basso I, Viswabandya A, Mattsson J, Pasic I. Pereira MP, et al. Among authors: chen c. Transplant Cell Ther. 2023 Nov;29(11):697.e1-697.e10. doi: 10.1016/j.jtct.2023.08.009. Epub 2023 Aug 12. Transplant Cell Ther. 2023. PMID: 37579919 Free article.
Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation.
Salas MQ, Atenafu EG, Law AD, Lam W, Pasic I, Chen C, Dong Hwan Kim D, Michelis FV, Gerbitz A, Lipton JH, Mattsson J, Kumar R, Viswabandya A. Salas MQ, et al. Among authors: chen c. Transplant Cell Ther. 2021 May;27(5):428.e1-428.e9. doi: 10.1016/j.jtct.2021.02.007. Epub 2021 Feb 13. Transplant Cell Ther. 2021. PMID: 33965185 Free article.
Pretransplant bone marrow cellularity and blood count recovery are not associated with relapse or survival risk following allogeneic stem cell transplant for AML in CR.
Novitzky-Basso I, Chen C, Chen S, Lipton JH, Kim DD, Viswabandya A, Kumar R, Lam W, Law A, Al-Shaibani Z, Gerbitz A, Pasic I, Mattsson J, Michelis FV. Novitzky-Basso I, et al. Among authors: chen c, chen s. Eur J Haematol. 2021 Sep;107(3):354-363. doi: 10.1111/ejh.13673. Epub 2021 Jun 14. Eur J Haematol. 2021. PMID: 34076909
Lower dose of ATG combined with post-transplant cyclophosphamide for HLA matched RIC alloHCT is associated with effective control of GVHD and less viral infections.
Salas MQ, Atenafu EG, Law AD, Lam W, Pasic I, Chen C, Kim DDH, Michelis FV, Gerbitz A, Lipton JH, Mattsson J, Kumar R, Viswabandya A. Salas MQ, et al. Among authors: chen c. Leuk Lymphoma. 2021 Dec;62(14):3373-3383. doi: 10.1080/10428194.2021.1966781. Epub 2021 Aug 26. Leuk Lymphoma. 2021. PMID: 34435547
Outcomes of Patients Diagnosed With Chronic Lymphocytic Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Results From a Tertiary Care Center.
Linn SM, Nampoothiri RV, Chen C, Pasic I, Al-Shaibani Z, Lam W, Law AD, Michelis FV, Kim DDH, Gerbitz A, Lipton J, Kumar R, Mattsson J, Viswabandya A. Linn SM, et al. Among authors: chen c. Hematol Oncol Stem Cell Ther. 2023 Apr 4;16(3):230-237. doi: 10.1016/j.hemonc.2021.09.008. Hematol Oncol Stem Cell Ther. 2023. PMID: 34856195 Free article.
Anti-thymocyte Globulin and Post-Transplant Cyclophosphamide do not abrogate the inferior outcome risk conferred by human leukocyte antigen-A and -B mismatched donors.
Novitzky-Basso I, Remberger M, Chen C, Ellison C, Pasic I, Lam W, Law A, Gerbitz A, Viswabandya A, Lipton JH, Kim DD, Kumar R, Michelis FV, Mattsson J. Novitzky-Basso I, et al. Among authors: chen c. Eur J Haematol. 2022 Apr;108(4):288-297. doi: 10.1111/ejh.13735. Epub 2021 Dec 27. Eur J Haematol. 2022. PMID: 34905239
91,531 results
You have reached the last available page of results. Please see the User Guide for more information.